-+ 0.00%
-+ 0.00%
-+ 0.00%

Biotech and Bristol-Myers Squibb published positive global phase 2 data from Pumitamig in advanced non-small cell lung cancer progressing after immunotherapy combined with chemotherapy.

智通财经·10/25/2026 07:33:03
语音播报
Biotech and Bristol-Myers Squibb published positive global phase 2 data from Pumitamig in advanced non-small cell lung cancer progressing after immunotherapy combined with chemotherapy.